| |
| Issue |
Title |
| |
| Vol 6, No 2 (2020) |
Diagnostic Value of Quantitative Parameters of DCE-MRI in Endometrial Carcinoma and Its Correlation with Clinicopathological Factors |
Abstract
PDF
|
|
Xinyi Fang |
| |
| Vol 3, No 3 (2017) |
Identification and verification of a pathogenic MLH1 mutation c.1145dupA in a Lynch syndrome family |
Abstract
PDF
|
|
Huang Feifei, Tao Xiang, Jiang Wei, Chen Jun, Feng Weiwei |
| |
| Vol 3, No 3 (2017) |
Significance of defining a pathogenic variant in hereditary cancer syndrome |
Abstract
PDF
|
|
Kwong-Kwok Wong |
| |
| Vol 6, No 5 (2020): Online First |
Effect of Paclitaxel Combined with Nedaplatin on Serum Tumor Markers, MMP-9 and VEGF Levels in Patients with Endometrial Cancer |
Abstract
PDF
|
|
Md. Ali Hossain, Noman Hossain |
| |
| Vol 4, No 6 (2018) |
Dysregulated TCA Cycle Pathway in Endometrial Cancer |
Abstract
PDF
|
|
Yuexin Liu |
| |
| Vol 1, No 1 (2015) |
Primary diffuse large B-cell lymphoma of endometrium |
Abstract
PDF
|
|
Yuqing Zou, Hongmin Zhao, Jianhua Gao, Hong Zhu, Yong Li, Jianhua Zheng |
| |
| Vol 1, No 1 (2015) |
Emerging molecular-targeted therapies—the challenging case of endometrial cancer |
Abstract
PDF
|
|
Ines Vasconcelos |
| |
| 1 - 7 of 7 Items |
|
